High-dose-rate interstitial brachytherapy for mobile tongue cancer: Preliminary results of a dose reduction trial

Journal of Contemporary Brachytherapy

Volumn 6, Issue 1, 2014, Pages 10-14

  Akiyama, Hironori ^a   Yoshida, Ken ^b   Yamazaki, Hideya ^c   Takenaka, Tadashi ^d   Kotsuma, Tadayuki ^d   Masui, Koji ^c   Yoshioka, Yasuo ^e   Arika, Takumi ^d   Shimizutani, Kimishige ^a   Tanaka, Eiichi ^d  

^a OSAKA DENTAL UNIVERSITY   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d OSAKA NATIONAL HOSPITAL   (Japan)

^e OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Dose reduction; High dose rate brachytherapy; Tongue cancer

Indexed keywords

LUGOL; SILICON;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RECURRENCE; CAUSE SPECIFIC SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HIGH DOSE RATE INTERSTITIAL BRACHYTHERAPY; HUMAN; LYMPH NODE METASTASIS; MALE; MOUTH DISCOMFORT; NECK METASTASIS; RADIATION DOSE FRACTIONATION; RADIATION DOSE REDUCTION; RESPIRATORY TRACT INFECTION; SPUTUM ASPIRATION; STAINING; TISSUE NECROSIS; TONGUE CANCER; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR VOLUME; VERY ELDERLY;

EID: 84899506443     PISSN: 1689832X     EISSN: None     Source Type: Journal    
DOI: 10.5114/jcb.2014.40726     Document Type: Article

References (28)

1. Pernot M, Malissard L, Hoffstetter S et al. The study of tumoral, radiobiological, and general health factors that influence results and complications in a series of 448 oral tongue carcinomas treated exclusively by irradiation. Int J Radiat Oncol Biol Phys 1994; 29: 673-679. (Pubitemid 24241305)
2. Fein DA, Mendenhall WM, Parsons JT et al. Carcinoma of the oral tongue: a comparisbbb on of results and complications of treatment with radiotherapy and/or surgery. Head Neck 1994; 16: 358-365. (Pubitemid 24188557)
3. Shibuya H, Hoshina M, Takeda M et al. Brachytherapy for stage I & II oral tongue cancer: an analysis of past cases focusing on control and complications. Int J Radiat Oncol Biol Phys 1993; 326: 351-358.
4. Hareyama M, Nishio M, Saito A et al. Results of cesium needle interstitial implantation for carcinoma of the oral tongue. Int J Radiat Oncol Biol Phys 1993; 25: 29-34. (Pubitemid 23029770)
5. Mazeron JJ, Crook JM, Benck V et al. Iridium 192 implantation of T1 and T2 carcinomas of the mobile tongue. Int J Radiat Oncol Biol Phys 1990; 19: 1369-1376.
6. Inoue T, Inoue T, Yoshida K et al. Phase III trial of high-vs. low-dose-rate interstitial radiotherapy for early mobile tongue cancer. Int J Radiat Oncol Biol Phys 2001; 51: 171-175. (Pubitemid 32758877)
7. Inoue T, Inoue T, Teshima T et al. Phase III trial of high and low dose rate interstitial radiotherapy for early oral tongue cancer. Int J Radiat Oncol Biol Phys 1996; 36: 1201-1204. (Pubitemid 27014507)
8. Kakimoto N, Inoue T, Inoue T et al. Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer. Radiother Oncol 2003; 68: 123-128. (Pubitemid 38367544)
9. Yamazaki H, Inoue T, Yoshida K et al. Brachytherapy for early oral tongue cancer: low dose rate to high dose rate. J Radiat Res 2003; 44: 37-40. (Pubitemid 38738753)
10. Mazeron JJ, Ardiet JM, Haie-Meder C et al. GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas. Radiother Oncol 2009; 91: 150-156.
11. Nag S, Cano ER, Demanes DJ et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma. Int J Radiat Oncol Biol Phys 2001; 50: 1190-1198. (Pubitemid 32727795)
12. Okamoto T, Akiyama H, Gamoh S et al. High-dose-rate interstitial brachytherapy for tongue cancer; a radiological and biological study from the perspective of late complications. J Osaka Dent Univ 2012; 46: 57-62.
13. Akiyama H, Yoshida K, Shimizutani K et al. Dose reduction trial from 60 Gy in 10 fractions to 54 Gy in 9 fractions schedule in High-dose-rate interstitial brachytherapy for early oral tongue cancer. J Radiat Res 2012; 53: 722-726.
14. McMahon J, Devine JC, McCaul JA et al. Use of Lugol's iodine in the resection of oral and oropharyngeal squamous cell carcinoma. Br J Oral Maxillofac Surg 2010; 48: 84-87.
15. Petruzzi M, Lucchese A, Baldoni E, et al. Use of Lugol's iodine in oral cancer diagnosis: an overview. Oral Oncol 2010; 46: 811-813.
16. Umeda M, Shigeta T, Takahashi H, et al. Clinical evaluation of Lugol's iodine staining in the treatment of stage I-II squamous cell carcinoma of the tongue. Int J Oral Maxillofac Surg 2011; 40: 593-596.
17. Yoshida K, Shimizutani K, Tanaka E, et al. Ultrasonographic monitoring of high dose rate interstitial implant using template technique for oral tongue cancer. Radiat Med 1999; 17: 337-341. (Pubitemid 29535697)
18. Yoshida K, Nose T, Koizumi M et al. The usefulness of metal markers for CTV-based dose prescription in high-dose-rate interstitial brachytherapy. J Jpn Soc Ther Radiol Oncol 2002; 14: 253-260. (Pubitemid 36083339)
19. Lau HY, Hay JH, Flores AD et al. Seven fractions of twice daily high dose-rate brachytherapy for node-negative carcinoma of the mobile tongue results in loss of therapeutic ratio. Radiother Oncol 1996; 39: 15-18. (Pubitemid 26135603)
20. Teshima T, Inoue T, Ikeda H et al. Phase I/II study of high-dose rate interstitial radiotherapy for head and neck cancer. Strahlenther Onkol 1992; 168: 617-621. (Pubitemid 23000873)
21. Inoue T, Inoue T. High-dose rate interstitial brachytherapy for mobile tongue cancer: Part 2. Phase III trial of HDR versus LDR interstitial brachytherapy for T1-T2N0 carcinoma of the mobile tongue. Jpn J Cancer Chemother 2000; 27: Suppl 2: S291-295.
22. Yamazaki Y, Inoue T, Yoshida K et al. Lymph node metastasis of early oral tongue cancer after interstitial radiotherapy. Int J Radiat Oncol Biol Phys 2004; 58: 139-146. (Pubitemid 38010347)
23. Benk V, Mazeron JJ, Grimard et al. Comparison of curietherapy versus external irradiation combined with curietherapy in stage II squamous cell carcinomas of the mobile tongue. Radiother Oncol 1990; 18: 339-347. (Pubitemid 20264679)
24. Pernot M, Malissard L, Aletti P et al. Iridium-192 brachytherapy in the management of 147 T2N0 oral tongue carcinomas treated with irradiation alone: comparison of two treatment techniques. Radiother Oncol 1992; 23: 223-228.
25. Shimizutani K, Koseki, Inoue T et al. Interstitial Brachytherapy for Carcinoma of the tongue Using microSelectron-HDR. Oral Radiology 2001; 17: 95-101.
26. Yoshida K, Yamazaki H, Takenaka T et al. A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer. Int J Radiat Oncol Biol Phys 2010; 77: 765-772.
27. Major T, Polgar Cs, Mangel L et al. CT based conformal brachytherapy treatment planning. Hungarian Oncology 2000; 44: 109-115.
28. Nishioka T, Homma A, Furuta Y et al. A novel approach to advanced carcinoma of the tongue: cases successfully treated with combination of superselective intra-arterial chemotherapy and external/high-dose-rate interstitial radiotherapy. Jpn J Clin Oncol 2006; 36: 822-826. (Pubitemid 47090740)